Diamedica
DMAC
Diamedica (DMAC) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.19
- EPS estimate
- −$0.20
- EPS surprise
- +5.43%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 10, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | −$0.20 | −$0.19 | +5.43% | $0.00 | SEC |
| Q1 2026 | May 6, 2026 | −$0.19 | −$0.19 | −2.37% | $0.00 | SEC |
| Q4 2025 | Mar 30, 2026 | −$0.18 | −$0.17 | +5.56% | $0.00 | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.16 | −$0.17 | −6.25% | $0.00 | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.19 | −$0.18 | +5.26% | $0.00 | SEC |
| Q1 2025 | May 13, 2025 | −$0.18 | −$0.18 | +0.00% | $0.00 | SEC |
| Q4 2024 | Mar 17, 2025 | −$0.17 | −$0.18 | −4.35% | $0.00 | SEC |
| Q3 2024 | Nov 13, 2024 | −$0.16 | −$0.15 | +3.23% | $0.00 | SEC |
| Q2 2024 | Aug 7, 2024 | −$0.16 | −$0.13 | +17.04% | $0.00 | SEC |
| Q1 2024 | May 8, 2024 | −$0.16 | −$0.14 | +10.66% | $0.00 | SEC |
| Q4 2023 | Mar 19, 2024 | −$0.14 | −$0.12 | +14.29% | $0.00 | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.13 | −$0.12 | +5.29% | $0.00 | SEC |
| Q2 2023 | Aug 14, 2023 | −$0.18 | −$0.16 | +9.45% | $0.00 | SEC |
| Q1 2023 | May 15, 2023 | −$0.16 | −$0.20 | −25.00% | $0.00 | SEC |
| Q4 2022 | Mar 28, 2023 | −$0.14 | −$0.14 | +0.00% | $0.00 | SEC |
| Q3 2022 | Nov 9, 2022 | −$0.15 | −$0.12 | +18.64% | $0.00 | — |
| Q2 2022 | Aug 10, 2022 | −$0.18 | −$0.13 | +27.78% | $0.00 | — |
| Q1 2022 | May 4, 2022 | −$0.20 | −$0.13 | +35.00% | $0.00 | — |
| Q4 2021 | Mar 14, 2022 | −$0.18 | −$0.11 | +38.03% | $0.00 | — |
| Q3 2021 | Nov 10, 2021 | −$0.23 | −$0.18 | +21.05% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Diamedica (DMAC) last report earnings?
Diamedica last reported on Aug 10, 2026, covering fiscal Q2 2026.
Did DMAC beat earnings estimates?
Yes. Diamedica reported EPS of −$0.19 for Q2 2026 against a −$0.20 estimate — a 5.43% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.